We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Respiri is a medical devices business based in Australia. Respiri shares (RSH) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Respiri has a trailing 12-month revenue of around $883,392. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
Long-term investing
Our top pick for
Low-cost broker
| 52-week range | $0.032 - $0.1025 |
|---|---|
| 50-day moving average | $0.0432 |
| 200-day moving average | $0.0545 |
| Target price | N/A |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.011 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.053
| 1 week (2022-06-20) | 35.90% |
|---|---|
| 1 month (2022-05-30) | 51.43% |
| 3 months (2022-03-30) | -7.02% |
| 6 months (2021-12-30) | -19.70% |
| 1 year (2021-06-30) | -20.90% |
|---|---|
| 2 years (2020-06-30) | -40.45% |
| 3 years (2019-06-28) | -39.77% |
| 5 years (2017-06-27) | 29.27% |
| Revenue TTM | $883,392 |
|---|---|
| Gross profit TTM | $122,543 |
| Return on assets TTM | -49.06% |
| Return on equity TTM | -93.84% |
| Profit margin | 0% |
| Book value | 0.007 |
| Market capitalisation | $42.7 million |
TTM: trailing 12 months
We're not expecting Respiri to pay a dividend over the next 12 months.
Respiri 's shares were split on a 1:20 basis on 31 July 2012. So if you had owned 20 shares the day before the split, the next day you would own 1 share. This wouldn't directly have changed the overall worth of your Respiri shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Respiri shares which in turn could have impacted Respiri 's share price.
Over the last 12 months, Respiri 's shares have ranged in value from as little as $0.032 up to $0.1025. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Respiri 's is -0.0553. This would suggest that Respiri 's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Respiri has bucked the trend.
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and Israel. The company develops, produces, and sells mobile health applications. Its products include Wheezo, an asthma management tool to help user understand their asthma by providing information, such as triggers, symptoms, medication usage, and other events. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.
Steps to owning and managing Kincora Copper shares.
Steps to owning and managing Arcadia Minerals shares.
Steps to owning and managing Nexgen Energy shares.
Steps to owning and managing Keypath Education shares.
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
Steps to owning and managing EBR Systems shares.
Steps to owning and managing 5E Advanced Materials shares.
Steps to owning and managing Leo lithium shares.
Steps to owning and managing Besra Gold shares.
